SOS2调节了突变EGFR依赖性瘤发生的值
Patricia L Theard1, Amanda J Linke1, Nancy E Sealover1
1Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA 20814.
针对无七之子2 (SOS2) 的目标可以克服肺腺癌中的 osimertinib 耐药性. 删除SOS2抑制了绕道信号,降低了对EGFR-TKI的抵抗力,并提高了治疗效率.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 信号传输 信号传输
背景情况:
- 无七之子1和2 (SOS1和SOS2) 是关键的RAS氨酸核酸交换因子 (RasGEFs),参与受体氨酸激酶 (RTK) 依存的RAS激活.
- 皮表皮生长因子受体氨酸激酶抑制剂 (EGFR-TKIs),如奥西默蒂尼布,在治疗肺腺癌 (LUAD) 中至关重要,但耐药性仍然是一个重大挑战.
结论:
- 向SOS2有可能克服由绕道RTK重新激活驱动的奥西默蒂尼布耐药性,这是LUAD治疗失败的主要原因.
- 删除SOS2显著降低了RTK/AKT依赖的 osimertinib 耐药性,这表明SOS2是治疗点.
更多相关视频
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
相关概念视频
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulation of Angiogenesis and Blood Supply
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
